Literature DB >> 19330848

Positive modulation of AMPA receptors prevents downregulation of GluR2 expression and activates the Lyn-ERK1/2-CREB signaling in rat brain ischemia.

Quan-Guang Zhang1, Dong Han, Shu-Qun Hu, Chong Li, Chang-Zhou Yu, Ran Wang, Guang-Yi Zhang.   

Abstract

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) are responsible for excitotoxicity induced by ischemic injury in hippocampal CA1 neurons, whereas the molecular mechanisms responsible for their neurotrophic activities are much less studied. Here, we examined the neuroprotective effect of positive modeulation of AMPARs by coapplication of AMPA with PEPA, an allosteric potentiator of AMPARs. We showed that coapplication of AMPA with PEPA protected hippocampal CA1 neurons from brain ischemia-induced death. Coapplication of AMPA with PEPA could prevent downregulated expression of GluR2 subunit caused by ischemia and increase BDNF expression via Lyn-ERK1/2-CREB signaling. Furthermore, TrkB receptor-mediated PI3K/Akt signal pathway was activated after coapplication of AMPA with PEPA, which was related to MAPK pathway and protected CA1 neurons against ischemic insults through depression of JNK3 activity, release of cytochrome c to cytosol and depression of capase-3 activity. Our results revealed that positive modulation of AMPARs could exert neuroprotective effects and the possible signaling pathways underlied. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19330848     DOI: 10.1002/hipo.20593

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  5 in total

1.  Combined ampakine and BDNF treatments enhance poststroke functional recovery in aged mice via AKT-CREB signaling.

Authors:  Andrew N Clarkson; Kim Parker; Michael Nilsson; F Rohan Walker; Emma K Gowing
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-11       Impact factor: 6.200

2.  Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Authors:  Brian P Brennan; James I Hudson; J Eric Jensen; Julie McCarthy; Jacqueline L Roberts; Andrew P Prescot; Bruce M Cohen; Harrison G Pope; Perry F Renshaw; Dost Ongür
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

Review 3.  Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.

Authors:  Nicholas L Weilinger; Valentyna Maslieieva; Jennifer Bialecki; Sarup S Sridharan; Peter L Tang; Roger J Thompson
Journal:  Acta Pharmacol Sin       Date:  2012-08-06       Impact factor: 6.150

Review 4.  The neuroprotective effect of dexmedetomidine and its mechanism.

Authors:  Yijun Hu; Hong Zhou; Huanxin Zhang; Yunlong Sui; Zhen Zhang; Yuntao Zou; Kunquan Li; Yunyi Zhao; Jiangbo Xie; Lunzhong Zhang
Journal:  Front Pharmacol       Date:  2022-09-20       Impact factor: 5.988

5.  Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors.

Authors:  Sylvie Bretin; Caroline Louis; Laure Seguin; Stéphanie Wagner; Jean-Yves Thomas; Sylvie Challal; Nathalie Rogez; Karine Albinet; Fabrice Iop; Nadège Villain; Sonia Bertrand; Ali Krazem; Daniel Bérachochéa; Stéphanie Billiald; Charles Tordjman; Alex Cordi; Daniel Bertrand; Pierre Lestage; Laurence Danober
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.